SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3jv3'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_C_TRPC81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.34A	1c9sB-3jv3A: undetectable 1c9sC-3jv3A: undetectable	1c9sB-3jv3A: 14.87 1c9sC-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_D_TRPD81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.29A	1c9sC-3jv3A: undetectable 1c9sD-3jv3A: undetectable	1c9sC-3jv3A: 14.87 1c9sD-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_F_TRPF81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	1c9sE-3jv3A: undetectable 1c9sF-3jv3A: undetectable	1c9sE-3jv3A: 14.87 1c9sF-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_G_TRPG81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	1c9sF-3jv3A: undetectable 1c9sG-3jv3A: undetectable	1c9sF-3jv3A: 14.87 1c9sG-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_K_TRPK81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.32A	1c9sJ-3jv3A: undetectable 1c9sK-3jv3A: undetectable	1c9sJ-3jv3A: 14.87 1c9sK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7A_A_PFLA4002_1 (SERUM ALBUMIN)	3jv3	INTERSECTIN-1 (Mus musculus)	3 / 3	PHE A1346 LEU A1353 SER A1263	None	0.92A	1e7aA-3jv3A: undetectable	1e7aA-3jv3A: 17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTF_A_TRPA81_0 (TRP RNA-BINDING ATTENUATION PROTEIN (TRAP))	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.32A	1gtfA-3jv3A: undetectable 1gtfK-3jv3A: undetectable	1gtfA-3jv3A: 14.87 1gtfK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UTD_D_TRPD81_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	1utdD-3jv3A: undetectable 1utdE-3jv3A: undetectable	1utdD-3jv3A: 14.87 1utdE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UTD_G_TRPG81_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.34A	1utdG-3jv3A: undetectable 1utdH-3jv3A: undetectable	1utdG-3jv3A: 14.87 1utdH-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E3H_A_HQEA303_1 (CARBONIC ANHYDRASE 2)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	VAL A1177 LEU A1204 THR A1205 THR A1206 VAL A1202	None	0.93A	4e3hA-3jv3A: undetectable	4e3hA-3jv3A: 23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R87_I_SPMI202_1 (SPERMIDINE N1-ACETYLTRANSFERASE)	3jv3	INTERSECTIN-1 (Mus musculus)	4 / 7	ASN A1247 GLU A1243 GLU A1242 TYR A1245	None	1.25A	4r87I-3jv3A: undetectable	4r87I-3jv3A: 21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WG0_E_CHDE104_0 (NUCLEAR RECEPTOR COACTIVATOR 2)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 11	LEU A1238 LEU A1312 ASN A1285 LEU A1288 LEU A1292	None	1.01A	4wg0C-3jv3A: undetectable 4wg0D-3jv3A: undetectable 4wg0E-3jv3A: undetectable	4wg0C-3jv3A: 4.33 4wg0D-3jv3A: 4.33 4wg0E-3jv3A: 4.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA903_0 (PROTEIN ARGONAUTE-2)	3jv3	INTERSECTIN-1 (Mus musculus)	4 / 6	LEU A1249 PRO A1371 GLU A1242 TYR A1245	None	1.29A	4z4gA-3jv3A: undetectable	4z4gA-3jv3A: 14.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZBQ_A_ACTA605_0 (SERUM ALBUMIN)	3jv3	INTERSECTIN-1 (Mus musculus)	4 / 6	TYR A1322 GLU A1242 ARG A1374 ASN A1285	None	1.28A	4zbqA-3jv3A: undetectable	4zbqA-3jv3A: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_A_TRPA101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eeuA-3jv3A: undetectable 5eeuB-3jv3A: undetectable	5eeuA-3jv3A: 14.87 5eeuB-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eeuD-3jv3A: undetectable 5eeuE-3jv3A: undetectable	5eeuD-3jv3A: 14.87 5eeuE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5eeuH-3jv3A: undetectable 5eeuI-3jv3A: undetectable	5eeuH-3jv3A: 14.87 5eeuI-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5eeuA-3jv3A: undetectable 5eeuK-3jv3A: undetectable	5eeuA-3jv3A: 14.87 5eeuK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEV_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eevD-3jv3A: undetectable 5eevE-3jv3A: undetectable	5eevD-3jv3A: 14.87 5eevE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEV_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eevH-3jv3A: undetectable 5eevI-3jv3A: undetectable	5eevH-3jv3A: 14.87 5eevI-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEV_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5eevA-3jv3A: undetectable 5eevK-3jv3A: undetectable	5eevA-3jv3A: 14.87 5eevK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eewD-3jv3A: undetectable 5eewE-3jv3A: undetectable	5eewD-3jv3A: 14.87 5eewE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5eewH-3jv3A: undetectable 5eewI-3jv3A: undetectable	5eewH-3jv3A: 14.87 5eewI-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5eewA-3jv3A: undetectable 5eewK-3jv3A: undetectable	5eewA-3jv3A: 14.87 5eewK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eexD-3jv3A: undetectable 5eexE-3jv3A: undetectable	5eexD-3jv3A: 14.87 5eexE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5eexH-3jv3A: undetectable 5eexI-3jv3A: undetectable	5eexH-3jv3A: 14.87 5eexI-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5eexA-3jv3A: undetectable 5eexK-3jv3A: undetectable	5eexA-3jv3A: 14.87 5eexK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eeyD-3jv3A: undetectable 5eeyE-3jv3A: undetectable	5eeyD-3jv3A: 14.87 5eeyE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5eeyH-3jv3A: undetectable 5eeyI-3jv3A: undetectable	5eeyH-3jv3A: 14.87 5eeyI-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5eeyA-3jv3A: undetectable 5eeyK-3jv3A: undetectable	5eeyA-3jv3A: 14.87 5eeyK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEZ_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5eezD-3jv3A: undetectable 5eezE-3jv3A: undetectable	5eezD-3jv3A: 14.87 5eezE-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEZ_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5eezH-3jv3A: undetectable 5eezI-3jv3A: undetectable	5eezH-3jv3A: 14.87 5eezI-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEZ_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5eezA-3jv3A: undetectable 5eezK-3jv3A: undetectable	5eezA-3jv3A: 14.87 5eezK-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF0_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5ef0D-3jv3A: undetectable 5ef0E-3jv3A: undetectable	5ef0D-3jv3A: 14.87 5ef0E-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF0_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5ef0H-3jv3A: undetectable 5ef0I-3jv3A: undetectable	5ef0H-3jv3A: 14.87 5ef0I-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF0_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5ef0A-3jv3A: undetectable 5ef0K-3jv3A: undetectable	5ef0A-3jv3A: 14.87 5ef0K-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF1_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5ef1D-3jv3A: undetectable 5ef1E-3jv3A: undetectable	5ef1D-3jv3A: 14.87 5ef1E-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF1_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5ef1H-3jv3A: undetectable 5ef1I-3jv3A: undetectable	5ef1H-3jv3A: 14.87 5ef1I-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF1_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5ef1A-3jv3A: undetectable 5ef1K-3jv3A: undetectable	5ef1A-3jv3A: 14.87 5ef1K-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF2_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5ef2D-3jv3A: undetectable 5ef2E-3jv3A: undetectable	5ef2D-3jv3A: 14.87 5ef2E-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF2_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5ef2H-3jv3A: undetectable 5ef2I-3jv3A: undetectable	5ef2H-3jv3A: 14.87 5ef2I-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF2_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5ef2A-3jv3A: undetectable 5ef2K-3jv3A: undetectable	5ef2A-3jv3A: 14.87 5ef2K-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF3_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.31A	5ef3D-3jv3A: undetectable 5ef3E-3jv3A: undetectable	5ef3D-3jv3A: 14.87 5ef3E-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF3_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 9	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.30A	5ef3H-3jv3A: undetectable 5ef3I-3jv3A: undetectable	5ef3H-3jv3A: 14.87 5ef3I-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF3_K_TRPK101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3jv3	INTERSECTIN-1 (Mus musculus)	5 / 10	GLY A1309 HIS A1398 THR A1389 HIS A1396 ILE A1308	None	1.33A	5ef3A-3jv3A: undetectable 5ef3K-3jv3A: undetectable	5ef3A-3jv3A: 14.87 5ef3K-3jv3A: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M78_A_SALA304_1 (CARBONIC ANHYDRASE 2)	3jv3	INTERSECTIN-1 (Mus musculus)	4 / 7	VAL A1177 LEU A1204 THR A1205 THR A1206	None	0.78A	5m78A-3jv3A: undetectable	5m78A-3jv3A: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUR_B_PFLB407_1 (PROTON-GATED ION CHANNEL)	3jv3	INTERSECTIN-1 (Mus musculus)	4 / 7	TYR A1378 ILE A1381 ILE A1382 ILE A1308	None	0.94A	5murB-3jv3A: 4.1	5murB-3jv3A: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND7_B_TA1B601_2 (TUBULIN BETA-2B CHAIN)	3jv3	INTERSECTIN-1 (Mus musculus)	3 / 3	THR A1253 PRO A1371 ARG A1374	None	0.76A	5nd7B-3jv3A: undetectable	5nd7B-3jv3A: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	3jv3	INTERSECTIN-1 (Mus musculus)	3 / 3	TYR A1322 ASN A1277 LEU A1281	None	0.84A	6b58A-3jv3A: undetectable	6b58A-3jv3A: 20.04

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C9S_C_TRPC81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.34A","1c9sB-3jv3A:undetectable;1c9sC-3jv3A:undetectable","1c9sB-3jv3A:14.87;1c9sC-3jv3A:14.87"],["1C9S_D_TRPD81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.29A","1c9sC-3jv3A:undetectable;1c9sD-3jv3A:undetectable","1c9sC-3jv3A:14.87;1c9sD-3jv3A:14.87"],["1C9S_F_TRPF81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","1c9sE-3jv3A:undetectable;1c9sF-3jv3A:undetectable","1c9sE-3jv3A:14.87;1c9sF-3jv3A:14.87"],["1C9S_G_TRPG81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","1c9sF-3jv3A:undetectable;1c9sG-3jv3A:undetectable","1c9sF-3jv3A:14.87;1c9sG-3jv3A:14.87"],["1C9S_K_TRPK81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.32A","1c9sJ-3jv3A:undetectable;1c9sK-3jv3A:undetectable","1c9sJ-3jv3A:14.87;1c9sK-3jv3A:14.87"],["1E7A_A_PFLA4002_1","SERUM ALBUMIN","3jv3","INTERSECTIN-1","Mus musculus",3,"PHE A1346;LEU A1353;SER A1263","None","0.92A","1e7aA-3jv3A:undetectable","1e7aA-3jv3A:17.98"],["1GTF_A_TRPA81_0","TRP RNA-BINDING ATTENUATION PROTEIN (TRAP)","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.32A","1gtfA-3jv3A:undetectable;1gtfK-3jv3A:undetectable","1gtfA-3jv3A:14.87;1gtfK-3jv3A:14.87"],["1UTD_D_TRPD81_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","1utdD-3jv3A:undetectable;1utdE-3jv3A:undetectable","1utdD-3jv3A:14.87;1utdE-3jv3A:14.87"],["1UTD_G_TRPG81_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.34A","1utdG-3jv3A:undetectable;1utdH-3jv3A:undetectable","1utdG-3jv3A:14.87;1utdH-3jv3A:14.87"],["4E3H_A_HQEA303_1","CARBONIC ANHYDRASE 2","3jv3","INTERSECTIN-1","Mus musculus",5,"VAL A1177;LEU A1204;THR A1205;THR A1206;VAL A1202","None","0.93A","4e3hA-3jv3A:undetectable","4e3hA-3jv3A:23.10"],["4R87_I_SPMI202_1","SPERMIDINE N1-ACETYLTRANSFERASE","3jv3","INTERSECTIN-1","Mus musculus",4,"ASN A1247;GLU A1243;GLU A1242;TYR A1245","None","1.25A","4r87I-3jv3A:undetectable","4r87I-3jv3A:21.38"],["4WG0_E_CHDE104_0","NUCLEAR RECEPTOR COACTIVATOR 2","3jv3","INTERSECTIN-1","Mus musculus",5,"LEU A1238;LEU A1312;ASN A1285;LEU A1288;LEU A1292","None","1.01A","4wg0C-3jv3A:undetectable;4wg0D-3jv3A:undetectable;4wg0E-3jv3A:undetectable","4wg0C-3jv3A:4.33;4wg0D-3jv3A:4.33;4wg0E-3jv3A:4.33"],["4Z4G_A_IPHA903_0","PROTEIN ARGONAUTE-2","3jv3","INTERSECTIN-1","Mus musculus",4,"LEU A1249;PRO A1371;GLU A1242;TYR A1245","None","1.29A","4z4gA-3jv3A:undetectable","4z4gA-3jv3A:14.78"],["4ZBQ_A_ACTA605_0","SERUM ALBUMIN","3jv3","INTERSECTIN-1","Mus musculus",4,"TYR A1322;GLU A1242;ARG A1374;ASN A1285","None","1.28A","4zbqA-3jv3A:undetectable","4zbqA-3jv3A:18.88"],["5EEU_A_TRPA101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eeuA-3jv3A:undetectable;5eeuB-3jv3A:undetectable","5eeuA-3jv3A:14.87;5eeuB-3jv3A:14.87"],["5EEU_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eeuD-3jv3A:undetectable;5eeuE-3jv3A:undetectable","5eeuD-3jv3A:14.87;5eeuE-3jv3A:14.87"],["5EEU_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5eeuH-3jv3A:undetectable;5eeuI-3jv3A:undetectable","5eeuH-3jv3A:14.87;5eeuI-3jv3A:14.87"],["5EEU_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5eeuA-3jv3A:undetectable;5eeuK-3jv3A:undetectable","5eeuA-3jv3A:14.87;5eeuK-3jv3A:14.87"],["5EEV_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eevD-3jv3A:undetectable;5eevE-3jv3A:undetectable","5eevD-3jv3A:14.87;5eevE-3jv3A:14.87"],["5EEV_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eevH-3jv3A:undetectable;5eevI-3jv3A:undetectable","5eevH-3jv3A:14.87;5eevI-3jv3A:14.87"],["5EEV_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5eevA-3jv3A:undetectable;5eevK-3jv3A:undetectable","5eevA-3jv3A:14.87;5eevK-3jv3A:14.87"],["5EEW_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eewD-3jv3A:undetectable;5eewE-3jv3A:undetectable","5eewD-3jv3A:14.87;5eewE-3jv3A:14.87"],["5EEW_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5eewH-3jv3A:undetectable;5eewI-3jv3A:undetectable","5eewH-3jv3A:14.87;5eewI-3jv3A:14.87"],["5EEW_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5eewA-3jv3A:undetectable;5eewK-3jv3A:undetectable","5eewA-3jv3A:14.87;5eewK-3jv3A:14.87"],["5EEX_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eexD-3jv3A:undetectable;5eexE-3jv3A:undetectable","5eexD-3jv3A:14.87;5eexE-3jv3A:14.87"],["5EEX_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5eexH-3jv3A:undetectable;5eexI-3jv3A:undetectable","5eexH-3jv3A:14.87;5eexI-3jv3A:14.87"],["5EEX_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5eexA-3jv3A:undetectable;5eexK-3jv3A:undetectable","5eexA-3jv3A:14.87;5eexK-3jv3A:14.87"],["5EEY_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eeyD-3jv3A:undetectable;5eeyE-3jv3A:undetectable","5eeyD-3jv3A:14.87;5eeyE-3jv3A:14.87"],["5EEY_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5eeyH-3jv3A:undetectable;5eeyI-3jv3A:undetectable","5eeyH-3jv3A:14.87;5eeyI-3jv3A:14.87"],["5EEY_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5eeyA-3jv3A:undetectable;5eeyK-3jv3A:undetectable","5eeyA-3jv3A:14.87;5eeyK-3jv3A:14.87"],["5EEZ_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5eezD-3jv3A:undetectable;5eezE-3jv3A:undetectable","5eezD-3jv3A:14.87;5eezE-3jv3A:14.87"],["5EEZ_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5eezH-3jv3A:undetectable;5eezI-3jv3A:undetectable","5eezH-3jv3A:14.87;5eezI-3jv3A:14.87"],["5EEZ_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5eezA-3jv3A:undetectable;5eezK-3jv3A:undetectable","5eezA-3jv3A:14.87;5eezK-3jv3A:14.87"],["5EF0_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5ef0D-3jv3A:undetectable;5ef0E-3jv3A:undetectable","5ef0D-3jv3A:14.87;5ef0E-3jv3A:14.87"],["5EF0_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5ef0H-3jv3A:undetectable;5ef0I-3jv3A:undetectable","5ef0H-3jv3A:14.87;5ef0I-3jv3A:14.87"],["5EF0_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5ef0A-3jv3A:undetectable;5ef0K-3jv3A:undetectable","5ef0A-3jv3A:14.87;5ef0K-3jv3A:14.87"],["5EF1_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5ef1D-3jv3A:undetectable;5ef1E-3jv3A:undetectable","5ef1D-3jv3A:14.87;5ef1E-3jv3A:14.87"],["5EF1_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5ef1H-3jv3A:undetectable;5ef1I-3jv3A:undetectable","5ef1H-3jv3A:14.87;5ef1I-3jv3A:14.87"],["5EF1_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5ef1A-3jv3A:undetectable;5ef1K-3jv3A:undetectable","5ef1A-3jv3A:14.87;5ef1K-3jv3A:14.87"],["5EF2_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5ef2D-3jv3A:undetectable;5ef2E-3jv3A:undetectable","5ef2D-3jv3A:14.87;5ef2E-3jv3A:14.87"],["5EF2_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5ef2H-3jv3A:undetectable;5ef2I-3jv3A:undetectable","5ef2H-3jv3A:14.87;5ef2I-3jv3A:14.87"],["5EF2_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5ef2A-3jv3A:undetectable;5ef2K-3jv3A:undetectable","5ef2A-3jv3A:14.87;5ef2K-3jv3A:14.87"],["5EF3_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.31A","5ef3D-3jv3A:undetectable;5ef3E-3jv3A:undetectable","5ef3D-3jv3A:14.87;5ef3E-3jv3A:14.87"],["5EF3_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.30A","5ef3H-3jv3A:undetectable;5ef3I-3jv3A:undetectable","5ef3H-3jv3A:14.87;5ef3I-3jv3A:14.87"],["5EF3_K_TRPK101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3jv3","INTERSECTIN-1","Mus musculus",5,"GLY A1309;HIS A1398;THR A1389;HIS A1396;ILE A1308","None","1.33A","5ef3A-3jv3A:undetectable;5ef3K-3jv3A:undetectable","5ef3A-3jv3A:14.87;5ef3K-3jv3A:14.87"],["5M78_A_SALA304_1","CARBONIC ANHYDRASE 2","3jv3","INTERSECTIN-1","Mus musculus",4,"VAL A1177;LEU A1204;THR A1205;THR A1206","None","0.78A","5m78A-3jv3A:undetectable","5m78A-3jv3A:13.03"],["5MUR_B_PFLB407_1","PROTON-GATED ION CHANNEL","3jv3","INTERSECTIN-1","Mus musculus",4,"TYR A1378;ILE A1381;ILE A1382;ILE A1308","None","0.94A","5murB-3jv3A:4.1","5murB-3jv3A:14.29"],["5ND7_B_TA1B601_2","TUBULIN BETA-2B CHAIN","3jv3","INTERSECTIN-1","Mus musculus",3,"THR A1253;PRO A1371;ARG A1374","None","0.76A","5nd7B-3jv3A:undetectable","5nd7B-3jv3A:21.67"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","3jv3","INTERSECTIN-1","Mus musculus",3,"TYR A1322;ASN A1277;LEU A1281","None","0.84A","6b58A-3jv3A:undetectable","6b58A-3jv3A:20.04"]]